| Catalog Number |
07976887190 |
| Medical Device Problem Code |
Non Reproducible Results (4029)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
06/01/2018
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
This event occurred in (b)(6).(b)(4).
|
| |
|
Event or Problem Description
|
|
The customer questioned thyroid results for 6 patient samples tested for elecsys ft4 ii (ft4 ii), elecsys ft3 iii (ft3 iii) and elecsys tsh (tsh) on a cobas e 801 module.The 6 patient samples were submitted for investigation where discrepant results were identified for ft4 ii, ft3 iii and tsh between the customer's e801 module, the centaur method, an e801 module used at the investigation site, a cobas 8000 e 602 module used at the investigation site and a cobas e 411 immunoassay analyzer used at the investigation site.It is not known if any incorrect results were reported outside of the laboratory.This medwatch will cover ft4 ii.Refer to medwatch with patient identifier (b)(4) for information on the tsh erroneous results and medwatch with patient identifier (b)(4) for information on the ft3 iii erroneous results.Refer to attached data titled "patient results" for the patient results.There was no allegation that an adverse event occurred.The serial number for the customer's e801 module was not provided.The patient samples were also treated and underwent polyethylene glycol (peg) testing.Refer to attached data titled "peg testing" for these results.The e602 module serial number was 1286-07.The e411 analyzer serial number was (b)(4).The e801 module serial number used at the investigation site was (b)(4).The ft4 ii reagent lot number used with the e602 module was 304962 with an expiration date of 01/31/2019.The ft4 ii reagent lot number used with the e411 analyzer was 304692 with an expiration date of 01/31/2019.The ft4 ii reagent lot number used with the e801 module at the investigation site was 304694 with an expiration date of 01/31/2019.
|
| |
|
Additional Manufacturer Narrative
|
|
It was clarified that the customer and investigation site were using the elecsys ft4 iii assay and not the elecsys ft4 ii assay as originally stated.Applicable fields in sections d and g were updated to reflect the correct product.
|
| |
|
Additional Manufacturer Narrative
|
|
The patient samples with discrepant tsh and ft4 iii results were not submitted for investigation.As the samples were not available, the investigation could not be completed for these patient samples.The investigation was unable to find a definitive root cause for the customer's tsh and ft4 iii results.
|
| |
|
Search Alerts/Recalls
|